CANDIS DAVIS: Open Payments
NPI 1679987804 · VALDOSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,911 in 71 payments from 14 companies in 2025. Trend: 2023 $1,562 · 2024 $2,132 · 2025 $1,911
Food & beverage: $1,711Education: $200
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $348 |
| Amgen Inc. | 10 | $249 |
| ABBVIE INC. | 10 | $235 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $203 |
| PFIZER INC. | 8 | $184 |
| UCB, Inc. | 8 | $155 |
| Lilly USA, LLC | 7 | $128 |
| LEO Pharma Inc. | 4 | $98 |
| GENZYME CORPORATION | 2 | $87 |
| Regeneron Healthcare Solutions, Inc. | 4 | $80 |
Products named: TREMFYA, OTEZLA, SKYRIZI, DUPIXENT, CIBINQO, Bimzelx, TALTZ, ILUMYA.
Industry payments across GA — which companies pay providers there.
